Shuanghe Peng Department of Pathology The Second Hospital of Tianjin Medical University Biography Publications Institution JoVE Articles Shuanghe Peng has not added a biography. If you are Shuanghe Peng and would like to personalize this page please email our Author Liaison for assistance. Publications Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer Frontiers in Genetics. 2022 | Pubmed ID: 35559045 Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response Against Prostate Cancer Vaccines. Jul, 2021 | Pubmed ID: 34358202 Intra-Familial Phenotypic Heterogeneity and Telomere Abnormality in Von Hippel- Lindau Disease: Implications for Personalized Surveillance Plan and Pathogenesis of VHL-Associated Tumors Frontiers in Genetics. 2019 | Pubmed ID: 31068970 Correction: Prognostic and Clinicopathological Value of P53 Expression in Renal Cell Carcinoma: a Meta-analysis Oncotarget. 11, 2018 | Pubmed ID: 30555638 Neutrophil-lymphocyte Ratio is a Predictor of Prognosis in Patients with Castration-resistant Prostate Cancer: a Meta-analysis Cancer Management and Research. 2018 | Pubmed ID: 30271208 Prognostic and Clinicopathological Value of PBRM1 Expression in Renal Cell Carcinoma Clinica Chimica Acta; International Journal of Clinical Chemistry. Nov, 2018 | Pubmed ID: 30006290 Platelet-lymphocyte Ratio Acts As an Independent Predictor of Prognosis in Patients with Renal Cell Carcinoma Clinica Chimica Acta; International Journal of Clinical Chemistry. May, 2018 | Pubmed ID: 29462592 Prognostic and Clinicopathological Significance of PD-L1 in Patients with Renal Cell Carcinoma: a Meta-analysis Based on 1863 Individuals Clinical and Experimental Medicine. May, 2018 | Pubmed ID: 29362922 Prognostic and Clinicopathological Value of P53 Expression in Renal Cell Carcinoma: a Meta-analysis Oncotarget. Nov, 2017 | Pubmed ID: 29254251 C-reactive Protein is a Predictor of Prognosis in Renal Cell Carcinoma Patients Receiving Tyrosine Kinase Inhibitors: A Meta-analysis Clinica Chimica Acta; International Journal of Clinical Chemistry. Dec, 2017 | Pubmed ID: 29080691 Экономичный и эффективный протокол для выделения и культивирования дендритных клеток, полученных из костного мозга, у мышей Huiqin Tang*1, Hui Xie*1, Zhun Wang1, Shuanghe Peng2, Wenli Ni1, Linpei Guo3 1Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, 2Department of Pathology, The Second Hospital of Tianjin Medical University, 3Department of Urology, The Affiliated Wuxi No.2 People’s Hospital of Nanjing Medical University JoVE 63125 Immunology and Infection
Экономичный и эффективный протокол для выделения и культивирования дендритных клеток, полученных из костного мозга, у мышей Huiqin Tang*1, Hui Xie*1, Zhun Wang1, Shuanghe Peng2, Wenli Ni1, Linpei Guo3 1Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, 2Department of Pathology, The Second Hospital of Tianjin Medical University, 3Department of Urology, The Affiliated Wuxi No.2 People’s Hospital of Nanjing Medical University JoVE 63125 Immunology and Infection
